Saturday 17 November 2012

Subscribe by RSS Subscribe by Email
ALR Technologies (ALRT)

Medicare and Medicaid Waste in Focus as CMS Administrator Departs Position

The New York Times published an article this past weekend titled, “Health Official Takes Parting Shot at Waste.”  Written by Robert Pear, the article focuses on commentary from Dr. Donald M. Berwick, the newly departed former administrator of the Centers …

Continue Reading...

Recent Posts

22nd Century Group (XXII)PE

22nd Century Rival Star Scientific Takes Public Pummeling

Unilife Commences Unifill Syringe Supply to Sanofi

Cardiology News: Cardiologist Need for Predictive Technology

Cancer

Cellceutix Corp (OTCQBCTIX)450x250

Kevetrin™ Showcased By Toxicon; Cellceutix Update

Cellceutix Corporation (OTCQB: CTIX), a biopharmaceutical company focused on

Cellceutix Corp (OTCQBCTIX)450x250

Cellceutix CEO States “Full Speed Ahead”

BEVERLY, MA--(Marketwire - May 23, 2011) - Cellceutix Corporation

Agenus (AGEN) EB-2

Agenus Announces Presentation of New Phase 2 Trial Data on Glioma Vaccine

Agenus Inc. (Nasdaq:AGEN) just announced that it will be

BioMedical Devices

Unilife Corporation (NASDAQUNIS) EB450x250

Unilife Commences Unifill Syringe Supply to Sanofi

Unilife Begins the Supplying of Product to Sanofi Unilife

CardioNexus EB

HEALTHCARE MEGATRENDS: Early Detection of At-Risk Heart Patients

The heart attack epidemic inherited from

Unilife Corporation (NASDAQUNIS) EB450x250

Unilife Device Chosen for Clinical Trial

The trend shift towards drug delivery devices becoming a

Stem Cell Research

How does the US Court of Appeal decision affect NeoStem ($NBS)?

NeoStem Subsidiary Honored with Awards

Bioheart Releases Corporate Power Point Presentation

Miscellaneous Biotechnology Research

Medicare and Medicaid Waste in Focus as CMS Administrator Departs Position

22nd Century Rival Star Scientific Takes Public Pummeling

CorMedix Receives SPA from FDA for Deferiprone Phase 3 trial

Breaking Biotechnology News & Articles

| Disclaimer

Powered by WordPress | EmergingBiotechs.com custom design work in conjunction with Orman